MENU
+Compare
MED
Stock ticker: NYSE
AS OF
Sep 25, 04:59 PM (EDT)
Price
$13.63
Change
-$0.20 (-1.45%)
Capitalization
150.03M

MED Medifast Forecast, Technical & Fundamental Analysis

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life... Show more

MED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MED with price predictions
Sep 24, 2025

Aroon Indicator for MED shows an upward move is likely

MED's Aroon Indicator triggered a bullish signal on September 23, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 136 similar instances where the Aroon Indicator showed a similar pattern. In of the 136 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 15, 2025. You may want to consider a long position or call options on MED as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for MED crossed bullishly above the 50-day moving average on September 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MED advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 51 cases where MED's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MED turned negative on September 24, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .

MED moved below its 50-day moving average on September 24, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MED declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MED broke above its upper Bollinger Band on September 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.695) is normal, around the industry mean (9.334). MED has a moderately high P/E Ratio (41.364) as compared to the industry average of (20.518). MED's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.536). MED has a moderately high Dividend Yield (0.089) as compared to the industry average of (0.040). P/S Ratio (0.313) is also within normal values, averaging (636.253).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MED’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MED’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

View a ticker or compare two or three
MED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MED is expected to report earnings to fall 236.36% to -30 cents per share on November 10

Medifast MED Stock Earnings Reports
Q3'25
Est.
$-0.30
Q2'25
Beat
by $0.44
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.24
Q3'24
Beat
by $0.63
The last earnings report on August 04 showed earnings per share of 21 cents, beating the estimate of -21 cents. With 134.08K shares outstanding, the current market capitalization sits at 150.03M.
A.I.Advisor
published Dividends

MED paid dividends on November 07, 2023

Medifast MED Stock Dividends
А dividend of $1.65 per share was paid with a record date of November 07, 2023, and an ex-dividend date of September 18, 2023. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of health and diet products

Industry PersonnelServices

Profile
Fundamentals
Details
Industry
Specialty Stores
Address
100 International Drive
Phone
+1 410 581-8042
Employees
634
Web
https://www.medifastinc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALPMF10.72N/A
N/A
Astellas Pharma, Inc.
SHASF0.19N/A
N/A
Shamaran Petroleum Corporation
TWIRF1.94N/A
N/A
Tree Island Steel Ltd.
UMICF16.17N/A
N/A
Umicore SA
ZPHYF0.04N/A
N/A
Zephyr Minerals Ltd

MED and Stocks

Correlation & Price change

A.I.dvisor tells us that MED and FTDR have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MED and FTDR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MED
1D Price
Change %
MED100%
-1.64%
FTDR - MED
23%
Poorly correlated
-1.87%
TNL - MED
22%
Poorly correlated
-1.03%
MCW - MED
22%
Poorly correlated
-1.48%
SCI - MED
22%
Poorly correlated
-0.38%
LIND - MED
20%
Poorly correlated
+0.31%
More

Groups containing MED

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MED
1D Price
Change %
MED100%
-1.64%
Commercial Services
category (190 stocks)
18%
Poorly correlated
-0.66%
Personnel Services
category (23 stocks)
15%
Poorly correlated
-1.12%